U.S. Markets open in 8 hrs 5 mins

Evolent Health, Inc. (EVH)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
14.77+0.33 (+2.29%)
At close: 4:00PM EST
Sign in to post a message.
  • G
    Gpabade
    #Evolent Health, Inc. ( $EVH) A trend reversal is taking place here. Buy rating: 7, target: 15.73, according to 9trading.
    http://www.foxchart.com/share/320499660EVH.png
  • a
    a
    more news 18% potential upside which ie bleak vs what we should see w Enagaged, yet something to push the stock up tomorrow!!

    https://www.directorstalkinterviews.com/evolent-health-inc-consensus-indicates-potential-17-7-upside/412859009
    Evolent Health, Inc found using ticker (EVH) now have 10 analysts in total covering the stock. The consensus rating is 'Buy'. The range between the high
    Evolent Health, Inc found using ticker (EVH) now have 10 analysts in total covering the stock. The consensus rating is 'Buy'. The range between the high
    www.directorstalkinterviews.com
    Bullish
  • Y
    Yahoo Finance Insights
    Evolent Health reached a 52 Week high at 14.80
  • a
    a
    Man EVH is taking a hit w the market..... when will we get the news
  • a
    a
    Wait and see this week it will pop big time when the news leak
    Bullish
  • Y
    Yahoo Finance Insights
    Evolent Health reached a 52 Week high at 14.65
  • T
    Texas
    Got my divi— sweet!
  • m
    money man mitch
    Sadly there will be no news, this is going down to 10$,
    Bearish
  • a
    a
    Engaged Capital took a large stake, rumor is they are making a bid to take the company private at a $22 offer
    Bullish
  • T
    Texas
    When is the dividend payout?
  • a
    a
    Healthcare are in a great position to accelerate in value, EVH is down >50% in a month which is an over reaction vs market w a beta of close to 1, further their sales are approaching $1B w a market cap at $450MM less than 50% of sales. The business has steadily improved EBITDA and is set to deliver a positive QTR soon. Under these circumstances it makes EVH an uniquely positioned buying opportunity. The fact the stock is dropping today is hard to decipher but for some over reactions/reallocations and potential margin calls. EVH meets the needs to reducing costs for the healthcare system representing the new way of healthcare and will benefit greatly from whats coming policy wise, and alike stocks addressing the healthcare systems with more efficiency such as TDOC which is valued at +10X sales.
  • C
    ComedyClubster
    EVH was trading in the $27-$28 range before Passport Health's travails cratered the pps. Now, with the sale to Molina it should slowly head back to the previous range, possibly higher because the rest of the business has grown. It will take a few months for that to happen. Slowly and steadily it will increase
    Bullish
  • Y
    Yahoo Finance Insights
    Evolent Health is up 8.19% to 12.68
  • p
    phil
    Baird Comments On Non-Renewal Of Passport's KY Medicaid Contract; Says Thinks Shares Will Be Range Bound ($6-$8) Until We Gain Insight On Potential Actions From Incoming KY Gov, Says Thinks It Is Possible He Will Redo Process And Award Passport A Contract
    10:21 am ET November 27, 2019 (Benzinga) Print
    Latest Ratings for EVH DateFirmActionFromTo

    Nov 2019MaintainsOverweight Mar 2019MaintainsOverweightOverweight Feb 2019MaintainsOverweightOverweight

    View More Analyst Ratings for EVH
    View the Latest Analyst Ratings

    © 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
  • J
    JohnD
    Canaccord Genuity Sticks to Its Buy Rating for Evolent

    Evolent Health (NYSE: EVH) Canaccord Genuity analyst Richard Close maintained a Buy rating on Evolent Health (EVH) yesterday and set a price target of $17.00. The company’s shares closed last Friday at $8.88.
  • J
    JohnD
    Timing is more uncertain than sequencing. Beshear will likely eliminate work requirements from Medicaid. That will justify a rebid on contracts. Passport will compete, and likely win, a share of new contract. Molina was the major beneficiary of Bevin’s original award - they have recently loss two other Medicaid state contracts.
    This will sort itself out within a few months - Long EVH
  • V
    Viking
    It doesn’t seem like a virus induced slowdown would decrease revenues for EVH. Hence I am still long but it might take a while to see movement besides a passport bump
  • M
    Michael
    I would like to hear how the will respond to this. Can they cut costs? How much net revenue will be lost? What is the liquidation value of passport if any? CEO mention he would liquidate passport according to an articLe.
  • M
    Matthew
    Missed on eps by just a little. Narrowed guidance. Best revenues. Partnership is really good.
  • S
    Sven O
    Spoken like their CFO - but let's get real for a moment. The EVH gross is always loosely correlated to the number of patients served by their clients. How have they increased that number of patients? Certainly not through the acquisition of new business. And organic growth has been what? Meanwhile, you talk about the elusive positive quarter while their enterprise value is in steady decline. The problem is, EVH is standing still while competitors aren't in a sector that is grow-or-die due to the advantages scale provides. Yes, there is some silver lining - but today's market, with EVH getting hit while the rest of the market rebounded feels like an accurate understanding of the company's flawed fundamentals. Show me multiple positive quarters. Or a significant new client. Or a new offering for existing clients. Or anything that says EVH is a growing concern.
    Bearish